Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Aug 2022 – 20 Aug 2026, limited by quant Large Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant Large Cap Fund | Nifty 100 |
|---|---|---|
| 12 Aug 2022 | ₹100.00 | ₹100.00 |
| 12 Dec 2022 | ₹104.22 | ₹104.09 |
| 14 Apr 2023 | ₹95.58 | ₹98.21 |
| 14 Aug 2023 | ₹108.99 | ₹107.65 |
| 15 Dec 2023 | ₹126.34 | ₹120.26 |
| 15 Apr 2024 | ₹149.29 | ₹127.90 |
| 16 Aug 2024 | ₹159.98 | ₹142.44 |
| 16 Dec 2024 | ₹157.84 | ₹142.86 |
| 17 Apr 2025 | ₹145.20 | ₹135.98 |
| 18 Aug 2025 | ₹155.99 | ₹141.96 |
| 18 Dec 2025 | ₹159.43 | ₹146.60 |
| 20 Apr 2026 | ₹156.37 | ₹140.63 |
| 20 Aug 2026 | ₹169.64 | ₹141.41 |
| Metric | quant · Direct · IDCW NAV ₹16.98 Very High risk ★★★★☆ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| +7.57% | -3.12% | |
| +15.58% | +9.35% | |
| — | +8.00% | |
| — | +7.97% | |
| +14.04% | +9.16% | |
| +12.69% | — | |
| +16.61% | +10.38% | |
| — | +9.26% | |
| — | +8.80% | |
| Risk | ||
| 15.96% | 14.48% | |
| 0.57 | 0.16 | |
| 0.79 | 0.21 | |
| -21.01% | -36.60% | |
| Nifty 100 | — | |
| +5.06% | +0.11% | |
| 1.13 | 0.98 | |
| 121.7% | 96.8% | |
| 99.6% | 98.3% | |
| 1.49% | 1.08% | |
| ₹3,172Cr | ₹1,495Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 58% | |
| Sanjeev Sharma | — | |
| 12 Aug 2022 | — | |
| 11 | — | |
| 71.0% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.